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Abstract 
Background and Aims 
In 2017, a total of 889 854 suspected cholera cases  with 2578 deaths were reported from 
Yemen , thus  WHO considered these figures to be the worst epidemic of cholera in 
recent history of humanity. The aims of the study were to determine the prevalence of 
Vibrio cholera and protozoa causes in severe diarrhea patients and the potential risk 
factors of the contracting Vibrio cholera. 
Materials and methods 
  Hospital-based diarrhoeal disease surveillance has been done for 12 days in Bany-
alharth district of Sana'a city, where all patients admitted with severe diarrhoea in all 
health centers in the area were enrolled and tested for Vibrio cholerae, and others causes. 
The study was conducted on 345 patients and demographic, clinical, and potential risk 
factors were collected, then stool specimens were collected and processed by standard 
methods. 
Results 
The prevalence of V.cholerae was 8.1%, intestinal Entamoeba histolytica was 50.7%, and 
Giardia lamblia was 6.7% and one case of EPEC while 42% of diarrheal cases were 
undiagnosed. There was slightly increasing in the rate of V.cholerae infection with 
increasing age with OR equal to 3.1 times (PV=0.02). Also there were significant risk 
factors of dispose sewages to surround environment (OR=3.4 times, PV=0.02) and  
reused Jerry can bottles for drinking water (OR=3.1, PV= 0.03). 
Conclusion, Vibrio cholera infection rate, and  intestinal protozoa infection rates were 
significantly high. The findings emphasize that there is cholera epidemic in Sana' city and 
diarrheal epidemic due to various diagnosed and non diagnosed pathogenic 
microorganisms which may predispose population of the study to significant health risks. 
KEYWORDS: Cholera; diarrhoea; prevalence; risk factors, Sana'a city, Saudi 
Aggression, Yemen. 
Introduction 
Cholera occurs following infection of the intestine by the O1 or O139 sero-groups of the 
bacterium Vibrio cholerae (1, 2,3,4). About 20% of infected individuals develop acute, 
watery diarrhoea and 10–20% of these progress severe watery diarrhoea (5). Even though 
case-fatality rates have dropped due to oral and intravenous rehydration therapy, cholera 
can cause severe disease because of its rapid onset; residents in low-income locations as 
Yemen are at particularly high risk of infection in areas where public health systems 
cannot cope with outbreaks as in Yemen in which about 60% of public health system 
have been destroyed by the Saudi aggression on Yemen for 3 years and still continue (6). 
   In 2017, a total of 889 854 suspected cholera cases were reported from Yemen, 
including 2578 deaths, to the World Health Organization (WHO) (6 ,7). So WHO 
considered these figures to be worst epidemic of cholera in recent history of humanity? 
As the fact that  the WHO considered reported figures from endemic areas of cholera are 
underestimates, as poor surveillance systems and fear of negative impact on trade and 
tourism in many countries likely led to under-reporting (8,7). WHO estimates that 
  
officially reported cases represent only 5–10% of the actual number occurring worldwide 
annually (6). Cholera is an endemic in Yemen (9). In Yemen, cholera occurs year-round 
with seasonal peaks typically before and after rainy seasons with limited number of cases 
(9). The true burden of cholera is unknown in Yemen due to the lack of a population-
based surveillance system. 
   The estimation of cholera prevalence is particularly important to take effective control 
measures, including the provision of clean water, improved hygiene and sanitation, and 
introduction of cholera vaccines. Oral cholera vaccines have been found to be safe and 
effective (10,11,12). However, modeling studies have shown that water and sanitation 
measures may provide an equally viable solution, especially in the long term, since the 
immunization granted by vaccines wanes over time (13,14,15). Two types of inactivated 
cholera vaccines are currently available: one containing recombinant cholera toxin B 
subunit and killed cholera whole cells (rBS-WC) and the other containing only killed 
cholera whole cells (WC) (16,17). Field trials demonstrated that both vaccines provided 
>50% protection for 3 years (16,18). However, the WC vaccine is cheaper, at US$1.85 
per dose in the public sector, with a protective efficacy of 66% during the third year of 
follow-up, as reported in a recent study from Kolkata, India (19). Credible data regarding 
incidence of cholera is currently unavailable in Yemen, which limits the validity of any 
cost-effectiveness evaluation of a potential intervention programme. The aims of the 
study were to determine the prevalence of Vibrio cholera and protozoa causes among 
Yemeni patients suffering from severe diarrhea and the potential risk factors of the 
contracting Vibrio cholera. 
Material and methods 
 Case definition:  We defined severe diarrhoea as frequent loose or liquid stools for 
which a person had to be admitted to a healthcare facility, or had to receive intravenous 
rehydration, or had died as a result of the diarrhoeal illness. 
Data collection:     Data including demographic data of the patients, clinical information, 
and potential risk factors as water sources, food ingestion, sewage discarding, etc. time of 
disease, time of collection the specimen, etc.  The findings were recorded in a form with 
laboratory results.  
Laboratory testing 
Following rectal swab or stool specimens collection, samples were immediately placed in 
Cary–Blair transport media. All samples were cultured in the Al-Thorah hospital 
microbiology laboratory using standard bacteriological methods (20,21). In the 
laboratory, the rectal swabs or stool specimens were incubated in alkaline peptone water 
(APW) at 37 °C for 4 h. The rectal swabs or stool specimens, as well as the 4-h broth 
enrichments, were inoculated by streaking on taurocholate-tellurite-gelatin agar (TTGA). 
Colonies resembling V. cholerae were agglutinated with antisera specific for V. 
cholerae O1 and V. cholerae O139 (21). 
Sample size 
We calculated the sample size for healthcare utilization survey in the catchment area of 
surveillance hospitals by using the sample size calculation,  we assumed that in the 
catchment area of Sana'a city-based surveillance health centers and hospitals there would 
be about 800 000 severe diarrhoea patients per year. With expected frequency of cholera 
among them equal to 8.1%, and with acceptable margin of error 2.9%, with design effect 
  
1 and for one cluster, we need at least 340 severe diarrhoeal cases in 95% confidence 
level. 
Cholera case definitions and data analysis 
All patients with positive colonies of V. cholerae and agglutinated with antisera specific 
for V. cholerae O1 and V. cholerae O139 were considered to have had cholera infection. 
To relate possible risk factors for cholera infection, the data were examined in a case-
control study format. For severe diarrhoeal cases with evidence of infection with V. 
cholerae were matched up with those who were V. cholerae negative.  Differences in 
categorical variables were assessed using Fisher's exact tests where appropriate. Ninety-
five percent confidence intervals for odds ratios were calculated according to the method 
of Cornfield and 95% confidence limits for simple proportions were calculated by an 
exact binomial method using EPI-INFO. 
Ethical approval 
The field team obtained written consent from the identified severe diarrhoeal cases or 
their guardians. Assent was taken from participants aged between 11 and 17 years. In the 
surveillance hospitals, consent was also obtained from patients with diarrhoea before 
collecting the stool specimen. The study protocol was reviewed and approved by the 
Ethics Committee of Sana'a University, Faculty of Medicine and Health Sciences. 
 Results 
The study includes 345 patients of sever diarrhoea in Sana'a city during a period of 
12 days, starting in July 1
st
 2017 and ending in July 12th 2017. The tested  patients  ages 
were  ranged from 1 years  to 65 years old, most of individuals were in age groups of  <5  
years  (47.8 %),  followed by  age group  5-10 years  (43.1 %),  while only 7.8% of the total 
were in age group 11-20  years and only 1.5% were in age group ≥ 21 years (table 1).  The 
prevalence of V.cholerae was 8.1%, 3.5% of them as single cause and 4.6% were 
suffering from co-infection of V.cholerae (4.4% with Entamoeba histolytica).  The 
prevalence of intestinal Entamoeba histolytica was 50.7%, in which 40.9% of them as 
single cause and 9.9% were suffering from co-infection with other micro-organisms.  The 
prevalence of intestinal Giardia lamblia was 6.7%, in which 2.6% of them as single cause 
and 4.1% were suffering from co-infection. However, a low prevalence of EPEC (0.6%) 
and H.nana (2%) were very low. On other hand 42% of diarrheal cases were undiagnosed 
(unknown causes) (table 2). 
 There was slightly increasing in the rate of  V.cholerae infection with increasing age, in 
which the highest rate occurred in age group 11-20 years old (15%), followed by 5-10 
years old (9.4%), while the rates in age group < 5 years old was 6.2%, and in ≥ 21 years 
were zero% (table 4). When the sources of drinking water versus V.cholerae infection 
were considered, there was a highly significant increasing in the rate of V.cholerae 
infection with Jerry can bottles using (16.1%, with OR= 3.1 times, CI=1.5-6.9, and 
PV=0.02). However, there was no significant association between V.cholerae infections 
and other sources of drinking water (table 4). There was a highly significant increasing in 
the rate of V.cholerae infection with dispose sewages to the house surround environment 
(rate=21%, with OR= 3.4 times, CI=1.1 – 10.9 times, PV=0.03). However, there was 
protective level of government sewage system against V.cholerae infections (table 5).  
Discussion 
  
This study provides data on prevalence and potential risk factors of cholera among severe 
diarrhoea in Sana'a city in Yemen which will be useful to inform decisions for effective 
control measures. 
  The study results show variability in rates at different age groups, in which there was 
slightly increasing in the rate of V.cholerae infection with increasing age (table 4). Our 
study results is similar to that observed in Bangladesh  that children cholera more 
frequently in older children compared to young children during diarrhoeal illness (4). 
Higher rate of cholera in older patients might be related to those older children exposed to 
risk factors that related to out-door activities. 
When the sources of drinking water versus V.cholerae infection were considered, there 
was a highly significant increasing in the rate of V.cholerae infection with Jerry can 
bottles using (16.1%, with OR= 3.1 times, CI=1.5-6.9, and PV=0.02) (table 4). Higher 
rate of cholera with Jerry can bottles using might be related to faecal contamination of 
drinking water sources or faecal contamination of the re-used jerry can bottles. 
There was a highly significant increasing in the rate of V.cholerae infection with dispose 
sewages to the house surround environment (rate=21%, with OR= 3.4 times, CI=1.1 – 
10.9 times, PV=0.03) (table 5).This risk might be related to faecal contamination of 
drinking water.  Bany Al-Harath distract is a densely populated area and has one of the 
largest concentrations of slums in Sana'a city. Slum settlements often have unhygienic 
latrines, poor garbage management systems, and sewers that overflow into houses. In 
most cases, latrines are linked with sewerage lines and municipal water pipes are 
commonly exposed to sewerage lines which may lead to faecal contamination of the 
supply water source.  
   In this study, the prevalence of intestinal Entamoeba histolytica was 50.7%, in which 
40.9% of them as single cause and 9.9% were suffering from co-infection with other 
micro-organisms, our study results were similar compared to previous studies done at 
Libya and others African countries in which intestinal Entamoeba histolytica was the 
most common cause of diarrhea among children (22,23). High prevalence of intestinal 
Entamoeba histolytica is attributed by poor personal hygienic practices and poor 
environmental sanitation. Also E. histolytica and G. lamblia can directly transmit through 
food-handlers to consumers if ingested via contaminated food and water because cysts do 
not need environmental maturation (24,25). 
 Finally, for the confirmation of cholera cases, this study used a conventional culture 
method which remains the gold standard, but this procedure may yield false-negative 
results in case of inactivation of V. cholerae by in vivo-vibriolytic action of the phage 
and/or non-cultivability induced as a result of host response (26,27,28). Rapid antigen-
based diagnostic tests for cholera dipstick assays have identified 0–32% more cases than 
the conventional culture method in detecting V. cholerae antigens in stool samples 
(26,29,30,31). By not accounting for culture-negative V. cholerae cases we are 
underestimating total cholera prevalence, but we did not adjust the prevalence 
calculations for culture negatives because we did not have molecular evidence from this 
population to estimate the magnitude of the correction. 
Conclusion, Vibrio cholera infection rate, and  intestinal protozoa infection rates were 
significantly high. The findings emphasize that there is cholera epidemic in Sana' city and 
diarrheal epidemic due to various diagnosed and non diagnosed pathogenic 
microorganisms which may predispose population of the study to significant health risks. 
  
Therefore, constant epidemiological surveillance and applying proper preventive 
measures through biannual routine parasitological tests and treatment of the infected 
cases along with the improvement of environmental sanitation are recommended. 
Acknowledgments: 
Authors acknowledge the financial support of MHP, Sana'a Yemen, and WHO Sana'a 
office. 
Conflict of interest: 
"No conflict of interest associated with this work”. 
References 
1-Snow J. On the mode of communication of cholera, 1855. Salud publica de 
Mexico. 1991;33:194–201. 
2-Sack DA, et al.  Cholera. Lancet. 2004;363:223–233. 
3-Nair GB, et al.  Spread of Vibrio cholerae O139 Bengal in India. Journal of Infectious 
Diseases. 1994;169:1029–1034. 
4- Paul R. C. , A. S. G. Faruque,  M. Alam, et al.  Incidence of severe diarrhoea due 
to Vibrio cholevae in the catchment area of six surveillance hospitals in Bangladesh 
Epidemiol  Infect. 2016  Apr; 144(5): 927–939. 
5-World Health Organization. Cholera outbreak: assessing the outbreak response and 
improving preparedness: Global Task Force on Cholera Control. 2004 
6-MHP Yemen, Electronic Disease Early Warning System (eDEWS) . Weekly 
Epidemiological Bulletin W46 2017 (Nov 13-Nov 19). 
7-WHO. Cholera surveillance and number of cases. Geneva: WHO; (Accessed 22 August 
2017). ( http://www.who.int/topics/cholera/surveillance/en/index.html). 
8-Kimball AM, Wong KY, Taneda K. An evidence base for international health 
regulations: quantitative measurement of the impacts of epidemic disease on international 
trade. Revue Scientifique et Technique (International Office of Epizootics) 2005;24:825–
832.  
9-MHP Yemen. ReliefWeb. Yemen – Cholera outbreak - DG ECHO Daily Map | 
23/11/2017 
10-Lopez AL, et al.  Cholera vaccines for the developing world. Human Vaccines.  2008; 
4: 165–169.  
11-Clemens JD, et al.  Field trial of oral cholera vaccines in Bangladesh: results of one 
year of follow-up. Journal of Infectious Diseases. 1988;158:60–69. 
12-Sur D, et al.  Efficacy and safety of a modified killed-whole-cell oral cholera vaccine 
in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled 
trial. Lancet. 2009;374:1694–1702. 
13-Andrews JR, Basu S. Transmission dynamics and control of cholera in Haiti: an 
epidemic model. Lancet. 2011;377:1248–1255. 
14-Bertuzzo E, et al.  Prediction of the spatial evolution and effects of control measures 
for the unfolding Haiti cholera outbreak. Geophysical Research Letters. 2011;38 L06403. 
15-Tuite AR, et al.  Cholera epidemic in Haiti, 2010: using a transmission model to 
explain spatial spread of disease and identify optimal control interventions. Annals of 
Internal Medicine. 2011;154:593–601. 
16-WHO. Cholera vaccines. Weekly Epidemiological Record. 2011;76:117–124. 
17-Chaignat CL, Monti V. Use of oral cholera vaccine in complex emergencies: what 
next? Summary report of an expert meeting and recommendations of WHO. Journal of 
Health, Population, and Nutrition. 2007;25:244–261.  
18-Clemens JD, et al.  Field trial of oral cholera vaccines in Bangladesh: results from 
three-year follow-up. Lancet. 1990;335:270–273. 
19-Sur D, et al.  Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: 
results from 3 years of follow-up of a randomized, controlled trial. PLoS Neglected 
Tropical Diseases. 2011;5:e1289.  
  
20-Alam M, et al.  Seasonal cholera caused by Vibrio cholerae sero-groups O1 and O139 
in the coastal aquatic environment of Bangladesh. Applied and Environmental 
Microbiology. 2006; 72:4096–4104. 
21-WHO. World Health Organization Guidelines for the laboratory diagnosis of 
cholera. Geneva: WHO Bacterial Disease Unit; 1974. 
22-Ali MB, Ghenghesh KS, Ben Aissa R, Abuhelfaia A, Dufani MA. Etiology of 
childhood diarrhea in Zliten-Libya. Saudi Med J. 2005;26:1759–65.  
23-El Ammari NE, Nair GA. Critical evaluation of the intestinal Protozoan parasites 
among Libyan and other African residents of Al-Khoms, Libya. J Entomol Zool 
Stud. 2015;3:42–6. 
24-Ghenghesh K S,  Ghanghish K,  BenDarif ET,  Khaled Shembesh,  and  Ezzadin 
Franka . Prevalence of Entamoeba histolytica, Giardia lamblia, and  Cryptosporidium  
spp. in Libya: 2000–2015. Libyan J Med. 2016; 11: 10. 
25-Cheesbrough M. Medical laboratory manual for tropical countries, 2nd ed. Oxford, 
Butterworth, 1992. 
26-Alam M, et al.  Diagnostic limitations to accurate diagnosis of cholera. Journal of 
Clinical Microbiology. 2010; 48:3918–3922.  
27-Colwell RR, et al.  Viable but non-culturable Vibrio cholerae O1 revert to a cultivable 
state in the human intestine. World Journal of Microbiology & 
Biotechnology. 1996;12:28–31.  
28-Faruque SM, et al.  Transmissibility of cholera: in vivo-formed biofilms and their 
relationship to infectivity and persistence in the environment. Proceedings of the National 
Academy of Sciences USA. 2006;103:6350–6355. 
29-Boncy J, et al.  Performance and utility of a rapid diagnostic test for cholera: notes 
from Haiti. Diagnostic Microbiology and Infectious Disease. 2013;76:521–523. 
30-Ley B, et al.  Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera 
in Zanzibar and a comparison with previous studies. PLoS ONE. 2012;7:e36930. 
31-Nato F, et al.  One-step immunochromatographic dipstick tests for rapid detection 
of Vibrio cholerae O1 and O139 in stool samples. Clinical and Diagnostic Laboratory 
Immunology. 2003;10:476–478.  
 
 
Table 1: Age distribution of the patients suffering from severs diarrhoea that tested for 
V.cholerae infection positivity in Sana'a city – Yemen, (July 2017). 
Age groups 
Total  (n =345 ) 
No. % 
< 5  years 165 47.8 
5 -  10  years 149 43.1 
11 - 20  years  27 7.8 
≥ 21 years 5 1.5 
 
  
Table 2: The frequency of different bacterial, protozoa and parasites that diagnosed among 
The patients suffering from severe diarrhoea whom tested for V.cholerae infection in 
Sana'a city – Yemen, (July 2017).   
Agents frequency 
Number percentage 
V.cholerae  
Single infection 
Co-infection  
28/345 
12/345 
16/345 
8.1 
3.5 
4.6 
Entamoeba histolytica  
Single infection 
Co-infection 
175/345 
141/345 
34/345 
50.7 
40.9 
9.9 
Giardia lamblia 
Single infection 
Co-infection 
23/345 
9/345 
14/345 
6.7 
2.6 
4.1 
H.nana 
Single infection 
Co-infection 
7/345 
3/345 
4/345 
2 
0.9 
1.2 
EPEC 
Single infection 
Co-infection 
2/345 
2/345 
0/345 
0.6 
0.6 
Undiagnosed 145/345 42 
Total diagnosed 200/345 58 
 
Table 3: The association between V.cholerae infections and the age groups of the patients 
suffering from severe diarrhoea in Sana'a city – Yemen, (July 2017). 
 
Age groups 
V.cholerae 
positive 
culture (n=28) 
OR CI χ 2 Pv 
No. % 
< 5  years n=162 10 6.2 0.6 0.26-1.3 1.5 0.21 
5-10  years n=149 14 9.4 1.3 0.1-2.9 0.57 0.44 
11 -20 years n=27 4 15 2.1 0.7-6.6 1.7 0.18 
≥ 21 years n=5 0 0 undefined 
Crude  rate 
N=345 
28 8.1  
OR          odds ratio = > 1 (risk) 
CI           Confidence intervals 1 to more than 1 
 X 2          Chi-square = > 3.9 (significant) 
 PV           Probability value = < 0.05 (significant) 
 
 
 
 
 
 
 
 
 
  
Table 4: The association between V.cholerae infections and the sources of drinking water 
for the patients suffering from severe diarrhoea in Sana'a city – Yemen, (July 2017). 
 
Water sources 
V.cholerae 
positive 
culture (n=28) 
OR CI χ 2 Pv 
No. % 
Water pump n=75 (21.7%) 3 4 0.4 0.11-1.3 2.1 0.14 
Hand well n=2 (0.6%) 0 0     
Water grid n=5(1.4%) 1 20 2.9 0.3-26 0.96 0.32 
Stream n=1(0.3%) 0 0     
Commercial containers n=131 
(38%) 
10 7.6 0.8 0.4-2 0.06 0.7 
Mineral water  n=11(3.2%) 1 9.1 1.1 0.4-9.2 0.01 0.9 
Reused Jerry can bottles  n=81 
(23.5%) 
13 16.1 3.1 1.5-6.9 8.9 0.02 
Crude  rate 
N=345 
28 8.1  
OR          odds ratio = > 1 (risk) 
CI           Confidence intervals 1 to more than 1 
 X 2          Chi-square = > 3.9 (significant) 
 PV           Probability value = < 0.05 (significant) 
 
Table 5: The association between V.cholerae infections and the swages system for the 
patients suffering from severe diarrhoea in Sana'a city – Yemen, (July 2017). 
 
Swages 
V.cholerae 
positive 
culture (n=28) 
OR CI χ 2 Pv 
No. % 
Doge hole n=244 (70.7%) 20 8.2 1.0 0.44-2.4 
0.00
7 
0.93 
Government sewage n=73 
(21.2%) 
4 5.5 0.6 0.2-1.7 0.86 0.35 
Dispose to surround 
environment n=19 (5.5%) 
4 21 3.4 1.1-10.9 4.5 0.03 
Crude  rate 
N=345 
28 8.1  
OR          odds ratio = > 1 (risk) 
CI           Confidence intervals 1 to more than 1 
 X 2          Chi-square = > 3.9 (significant) 
 PV           Probability value = < 0.05 (significant) 
 
